Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to oversee the agency’s program for vaccines and biotech drugs.FDA Commissioner Dr.

The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of more stringent approval standards, to lead the agency’s vaccines

Agency commissioner Dr. Marty Makary announced Tuesday that Dr. Vinay Prasad, a prominent COVID–19 vaccine critic, has been appointed to lead the Food and Drug Administration Center, which oversees the approval of vaccines and other biologics products.

U.S. President Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharmaceutical plants in the country, as part of new regulations to encourage domestic manufacturing.

President Donald Trump signed an executive order to encourage domestic prescription drug manufacturing and cut down on the time it takes to approve U.S. pharmaceutical plants.

The order directs the U.S. Food and Drug Administration to reduce the time it takes to approve drug manufacturing plants in the country, as well as to increase fees for inspections at foreign sites, according to the newspaper.